IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 3 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,240,871 | -14.9% | 2,470,521 | +31.6% | 0.40% | -33.2% |
Q2 2023 | $13,212,771 | +4.9% | 1,876,814 | -9.0% | 0.60% | -15.6% |
Q1 2023 | $12,597,684 | -4.4% | 2,061,814 | 0.0% | 0.71% | -21.6% |
Q4 2022 | $13,174,991 | +46.9% | 2,061,814 | +120.3% | 0.91% | +4.0% |
Q3 2022 | $8,967,000 | -50.0% | 936,000 | -42.4% | 0.87% | -53.5% |
Q2 2022 | $17,940,000 | +52.8% | 1,625,000 | +130.5% | 1.88% | +24.7% |
Q1 2022 | $11,738,000 | +17.1% | 705,000 | +34.3% | 1.51% | +13.6% |
Q4 2021 | $10,022,000 | – | 525,000 | – | 1.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |